7 studies found for:    DOCK8
Show Display Options
Rank Status Study
1 Recruiting Pilot Study of Reduced-Intensity Hematopoietic Stem Cell Transplant of DOCK8 Deficiency
Condition: DOCK8 Deficiency
Interventions: Drug: Fludarabine(Fludara, Berlex Laboratories);   Drug: Cyclophosphamide(CTX, Cytoxan);   Procedure: Total Body Irradiation (TBI);   Drug: Equine ATG;   Drug: Busulfan (Busulfex)
2 Recruiting Apheresis of Patients With Immunodeficiency
Conditions: LAD-1;   DOCK8;   MonoMAC
Intervention:
3 Recruiting Detection and Characterization of Infections and Infection Susceptibility
Conditions: Immune Disorders;   Chronic Granulomatous Disease;   Genetic Immunological Deficiencies;   Hyperimmunoglobulin-E Recurrent Infection Syndrome;   Recurrent Infections;   Unknown Immune Deficiency;   GATA2 Deficiency (MonoMAC),;   Nontuberculous Mycobacterial Infections;   Hyper IgE (Job s) Syndrome;   Leukocyte Adhesion Deficiency;   Susceptibility to Disseminated Infections;   Primary Immune Deficiency Disease (PIDD)
Intervention:
4 Recruiting Study of Clinical Features and Genetics of Hyperimmunoglobulin E Recurrent Infection
Condition: Job's Syndrome
Intervention:
5 Recruiting Studies of Skin Microbes in Healthy People and in People With Skin Conditions
Conditions: Atopic Dermatitis;   Eczema;   Ichthyosis Vulgaris
Intervention:
6 Completed Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)
Condition: Gastroesophageal Reflux Disease (GERD)
Interventions: Drug: Rabeprazole sodium;   Drug: Esomeprazole
7 Completed A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C. Difficile-Associated Diarrhea
Conditions: Clostridium Enterocolitis;   Diarrhea
Intervention: Drug: Tolevamer potassium-sodium (GT267-004)

Indicates status has not been verified in more than two years